Rosen Law Firm & ADMA Biologics
2 shared events · Importance 3 · Last updated Jul 20, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Rosen Law Firm: Rosen Law Firm is investigating potential securities claims and has filed a class action lawsuit against ADMA Biologics for allegedly issuing materially misleading business information.
ADMA Biologics: ADMA Biologics is the primary subject of the class action lawsuits and investigations due to allegations of channel stuffing, undisclosed related-party transactions, and misleading revenue growth, which caused its stock price to decline significantly.
Apr 01, 2026 · 301 articles
Regulatory
Rosen Law Firm: The Rosen Law Firm is a lead plaintiff in the class action, having filed the first complaint. It is actively recruiting investors and stands to gain from a favorable outcome.
ADMA Biologics: ADMA Biologics is the defendant in the securities class action, accused of making false and misleading statements. The lawsuit and allegations have led to a significant drop in its stock price and could result in substantial financial penalties and reputational harm.
Jun 14, 2026 · 294 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Rosen Law Firm and ADMA Biologics interact across events, view sentiment trends, and discover connected entities.
Open Dashboard